| Literature DB >> 25542607 |
Abstract
Acute dysfunction of a kidney transplant can be the result of many different etiologies and an allograft biopsy is frequently necessary to diagnose acute rejection. This invasive procedure, while generally safe, is time consuming, costly and inconvenient. We summarize recent advances in genomic and proteomic techniques using peripheral blood and urine for the diagnosis of acute rejection. While much progress has been made, validation of these new molecular tests in the clinical setting is still required. Published by Elsevier Inc.Entities:
Mesh：
Substances：
Year: 2014 PMID： 25542607 PMCID： PMC4397134 DOI： 10.1016/j.trre.2014.12.003
Source DB: PubMed Journal: Transplant Rev (Orlando) ISSN： 0955-470X Impact factor: 3.943